Because of the donation from Lutronic, we are now able to utilize the Spectra laser for treating a variety of treatments, including disfiguring pigmented lesions.
Fremont, CA (PRWEB) February 26, 2014
Lutronic Corporation, a leading innovator in advanced aesthetic and medical laser technology around the world, reported today that it has donated its Dual-pulsed Q-switched Nd:YAG SPECTRA™ laser to bring hope to Vietnamese children who are suffering from disfiguring pigmented lesions.
The specialized device was donated to the Vietnam Vascular Anomalies Center (VAC) at Nguyen Tri Phuong Hospital in Vietnam. The Vietnam Vascular Anomalies Center (VAC) is in partnership with Harvard Medical School, Massachusetts General Hospital and Beckman Laser Institute, the University of Medicine and Pharmacy of Ho Chi Minh City and Baylor College of Medicine to treat children with disfiguring pigmented lesions, vascular lesions, burn scars, radiation-related damage and other skin abnormalities.
Dr. Rox Anderson, a dermatologist at Harvard Medical School and a world renowned leader in laser technology and application for more than two decades, has been donating his time to treat children in Vietnam and providing education to local physicians.
"All children, regardless of country or financial situation, deserve a chance to look normal. Helping children is the best thing I do – I am glad that I can help children of all walks of life around the globe, and I am especially gratified that I am able to help the children in Vietnam. Because of the donation from Lutronic, we are now able to utilize the SPECTRA laser for treating a variety of treatments, including disfiguring pigmented lesions," said Dr. Anderson.
Lutronic also asked Dr. B.L. Goo who is an expert in treating pigmented lesions to fly over to Vietnam to train local physicians and demonstrate laser procedures on patients with the SPECTRA laser system which enables effective clinical results over a wide range of pigmented lesions.
"We are very pleased to participate in this global collaboration with leading physicians and organizations to help infants and children by donating the SPECTRA laser and we especially want to applaud physicians and organizations that bring renewed hope to these children," said Lutronic CEO and President Haelyung Hwang.
Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 17 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, skin resurfacing, body/facial contouring, chronic pain and more.
With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 240 intellectual properties including current and pending patents worldwide. With more than 250 employees worldwide, Lutronic has offices in the US, Korea, China, Japan, and Europe, a worldwide network of distributors, and is ever expanding.
For more information about Lutronic and its products, please visit: http://www.lutronic.com.